Erlangen, Germany

Eberhard Stock

This inventor holds 1 USPTO granted patent. Top assignee: Applied Radiation Corporation. Active years: 1979.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eberhard Stock: Innovator in Radiation Therapy Technology

Introduction

Eberhard Stock is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of radiation therapy, particularly through his innovative patent related to electron accelerators.

Latest Patents

Eberhard Stock holds a patent for an "Electron accelerator comprising a target exposed to the electron beam." This invention aims to provide a dose rate that remains as constant as possible over the cross-section of the x-ray cone used in radiation therapy. This is especially crucial at lesser tissue depths, such as 3 cm. The design includes roughened surfaces on the collimator that define the margin of the x-ray cone. These surfaces are enhanced by grooves that are transverse to the radiation direction, featuring semicircular or step-shaped cross-sectional configurations. The grooves are advantageously formed in a thin-walled sleeve made of low atomic number material.

Career Highlights

Eberhard Stock is associated with Applied Radiation Corporation, where he continues to develop and refine technologies that enhance radiation therapy. His work is pivotal in improving treatment outcomes for patients undergoing radiation therapy.

Collaborations

Eberhard has collaborated with Leonhard Taumann, contributing to advancements in their field through shared expertise and innovative ideas.

Conclusion

Eberhard Stock's contributions to radiation therapy technology exemplify the impact of innovative thinking in medical applications. His patent reflects a commitment to improving patient care through advanced engineering solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…